Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing
HLA · 2024-03 · 103 (3)
DOI: 10.1111/tan.15441 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 20.03.2024. Verfasst von Magali Devriese und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France. Hauptthemen laut MEDLINE: Nanopore Sequencing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
The current practice of HLA genotyping in deceased donors poses challenges due to limited resolution within time constraints. Nevertheless, the assessment of compatibility between anti‐HLA sensitized recipients and mismatched donors remains a critical medical need, particularly when dealing with allele‐specific (second field genotyping level) donor‐specific antibodies. In this study, we present a customized protocol based on the NanoTYPE® HLA typing kit, employing the MinION® sequencer, which enables rapid HLA typing of deceased donors within a short timeframe of 3.75 h on average at a three‐field resolution with almost no residual ambiguities. Through a prospective real‐time analysis of HLA typing in 18 donors, we demonstrated the efficacy and precision of our nanopore‐based method in comparison to the conventional approach and without delaying organ allocation. Indeed, this duration was consistent with the deceased donor organ donation procedure leading to organ allocation via the French Biomedicine Agency. The improved resolution achieved with our protocol enhances the security of organ allocation, particularly benefiting highly sensitized recipients who often present intricate HLA antibody profiles. By overcoming technical challenges and providing comprehensive genotyping data, this approach holds the potential to significantly impact deceased donor HLA genotyping, thereby facilitating optimal organ allocation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
- INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
- Omixon Biocomputing Ltd., Budapest, Hungary.
ORCID-Profile: Magali Devriese, Vincent Allain, Lisa E Creary, Sophie Caillat-Zucman, Gregory Werner, Jean-Luc Taupin
Förderung
- Fondation pour la Recherche Médicale
Zitieren
APA
Devriese, M., Da Silva, S., Le Mene, M., Rouquie, J., Allain, V., Kolesar, L., Rigo, K., Creary, L. E., Lauterbach, N., Usureau, C., Dewez, M., Caillat-Zucman, S., Werner, G., & Taupin, J. L. (2024). Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing. HLA, 103(3). https://doi.org/10.1111/tan.15441
Vancouver
Devriese M, Da Silva S, Le Mene M, Rouquie J, Allain V, Kolesar L, et al. Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing. HLA. 2024;103(3). doi:10.1111/tan.15441
BibTeX
@article{Devriese2024,
author = {Devriese, Magali and Da Silva, Sephora and Le Mene, Melchior and Rouquie, Julien and Allain, Vincent and Kolesar, Libor and Rigo, Krisztina and Creary, Lisa E and Lauterbach, Nina and Usureau, Cedric and Dewez, Mathieu and Caillat-Zucman, Sophie and Werner, Gregory and Taupin, Jean-Luc},
title = {Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing},
journal = {HLA},
year = {2024},
volume = {103},
number = {3},
doi = {10.1111/tan.15441}
}
EUVIMED